

Transforming MedicineImproving Lives

Building for greater impact
Mr Goh Yew Lin
Chair, Governing Board, Duke-NUS Medical School


Building for greater impact
Duke-NUS was created for a clear purpose. It was meant to bring a different model of medical education and research to Singapore. That purpose remains relevant today.
Mr Goh Yew Lin
Chair, Governing Board, Duke-NUS Medical School


Writing Duke-NUS’ next chapter
Looking ahead, Duke-NUS will continue to build the future of medicine on this foundation with science, clarity and ambition


Driven by
purpose,
powered by people
Professor Thomas M Coffman
Former Dean, Duke-NUS Medical School

Professor Patrick Tan
Current Dean, Duke-NUS Medical School
Looking ahead, Duke-NUS will continue to build the future of medicine on this foundation with science, clarity and ambition

Governing Board
Mr Goh Yew Lin
Chief Executive Officer, G. K. Goh Holdings Pte. Ltd.
Prof Aaron Thean
Deputy President (Academic Affairs) and Provost, National University of Singapore

Governing Board
Mr Goh Yew Lin
Chief Executive Officer, G. K. Goh Holdings Pte. Ltd.
Prof Aaron Thean
Deputy President (Academic Affairs) and Provost, National University of Singapore

Member
Dr Fidah Alsagoff
Chair of ClavystBio Pte Ltd.
Prof Edward G Buckley
Vice President of Duke-NUS Affairs, Chair, Department of Ophthalmology Duke University School of Medicine
Mr Chng Hak-Peng
Chair of School Advisory Committee, Chua Chu Kang Secondary School
Ms Karen Chong
Coordinating Divisional Director, Higher Educational Group, Ministry of Education

Member
Dr Fidah Alsagoff
Chair of ClavystBio Pte Ltd.
Prof Edward G Buckley
Vice President of Duke-NUS Affairs, Chair, Department of Ophthalmology Duke University School of Medicine
Mr Chng Hak-Peng
Chair of School Advisory Committee, Chua Chu Kang Secondary School
Ms Karen Chong
Coordinating Divisional Director, Higher Educational Group, Ministry of Education


Stories that define us

Stories that define us


Catalytic
T cells’ capability to fully prevent acute viral infections opens new avenues for vaccine development
Duke-NUS findings show T cells can independently prevent acute viral infections to an extent previously thought only possible with neutralising antibodies.
T cells’ capability to fully prevent acute viral infections opens new avenues for vaccine development
Duke-NUS findings show T cells can independently prevent acute viral infections to an extent previously thought only possible with neutralising antibodies.
65LAB awards US$1.5 million to Duke-NUS platform to advance antifibrotic drug discovery
Professor Enrico Petretto leads research to develop new drugs for lung disease and uncover new therapeutic targets for kidney disease, augmenting gene analysis with AI and quantum computing.
Duke-NUS sharpens focus on population health to curb rising healthcare costs and chronic disease burden
Rebranded Health Services Research and Population Health (HSRPH) Programme reflects Duke-NUS focus on population health research and technology-enabled solutions.
Scientists build detailed map of the developing human brain, opening new pathways for Parkinson’s treatment
Offering unprecedented precision in profiling cell characteristics and cultivation methods, the map is a major step forward in new therapies for neurological conditions such as Parkinson’s.


Game-changing energy supercomplex promises better options for heart disease treatment
A new protein supercomplex in mitochondria that enhances energy production, offering potential hope for heart disease patients, has been discovered by Duke-NUS scientists.
Singapore scientists reveal gut microbes’ hidden role in anxiety—Could probiotics be the next mental health breakthrough?
Duke-NUS and NNI discovers that microbe secreting metabolites—indoles—alleviate anxiety levels, suggesting new probiotic-based therapies for mental health.
Duke-NUS study targets proteins to reverse lung scarring
YAP and TAZ proteins found to drive scar-forming cells in pulmonary fibrosis, offering potential new pathways to treat this life-threatening lung disease through inhibition.
Singapore launches national standard to validate antimicrobial disinfectant products
New Singapore Standard (SS) 705 provides a first-of-its-kind Singapore-developed assessment for the effectiveness and durability of antibacterial, antiviral and antifungal surface disinfectants and coatings.
Duke-NUS and T Cell Diagnostics team up to simplify T-cell analysis
Duke-NUS spin off developed point-of-care assays that could simplify the analysis of T-cell responses and provide rapid results for doctors and researchers.
A new protein supercomplex in mitochondria that enhances energy production, offering potential hope for heart disease patients, has been discovered by Duke-NUS scientists.
Read More Game-changing energy supercomplex promises better options for heart disease treatment
Duke-NUS and NNI discovers that microbe secreting metabolites—indoles—alleviate anxiety levels, suggesting new probiotic-based therapies for mental health.
Read More Singapore scientists reveal gut microbes’ hidden role in anxiety—Could probiotics be the next mental health breakthrough?
YAP and TAZ proteins found to drive scar-forming cells in pulmonary fibrosis, offering potential new pathways to treat this life-threatening lung disease through inhibition.
Read More Duke-NUS study targets proteins to reverse lung scarring
New Singapore Standard (SS) 705 provides a first-of-its-kind Singapore-developed assessment for the effectiveness and durability of antibacterial, antiviral and antifungal surface disinfectants and coatings.
Read More Singapore launches national standard to validate antimicrobial disinfectant products
Duke-NUS spin off developed point-of-care assays that could simplify the analysis of T-cell responses and provide rapid results for doctors and researchers.
Read More Duke-NUS and T Cell Diagnostics team up to simplify T-cell analysis

Connected
Family affair: Duke and NUS reunite in Singapore
Leadership from Duke, NUS, Duke-NUS and SingHealth gathered for a historic reunion in Singapore, celebrating 20 years of partnership and exploring future collaborations in education and research.
Family affair: Duke and NUS reunite in Singapore
Leadership from Duke, NUS, Duke-NUS and SingHealth gathered for a historic reunion in Singapore, celebrating 20 years of partnership and exploring future collaborations in education and research.
SingHealth Duke-NUS Academic Medical Centre leads S$10m national effort to tackle muscle-loss in ageing Singapore
Dedicated to sarcopenia, MAGNET aims to revolutionise diagnosis and treatment for Asian patients with a unique collection of samples from patients and state-of-the-art investigative platforms.
Endearing moments that help endure: Camp Simba’s largest edition yet builds bonds of joy and resilience
Medical students from Duke-NUS, NUS, and NTU organised Camp Simba 2025, a three-day event for 61 children with family members battling cancer, providing support and joy through bonding activities.
Asia PGI and partners unveil preview of PathGen: new AI-powered outbreak intelligence tool
Sovereign-by-design platform built for secure, decentralised pathogen intelligence-sharing across borders aims to break data silos and provide faster time to actionable insight of outbreaks.


PBSTA 2025: Strengthening bonds and building joy for young cancer patients
Hosted by Duke-NUS students, the 2025 Paediatric Brain and Solid Tumour Awareness Day at Gardens by the Bay offered young cancer patients and families vital support and community.
Empowering Duke-NUS’ “Clinician Plus” at inaugural community forum
The inaugural forum discussed support strategies for clinician-scientists to achieve their aspirations in their dual roles, and saw over S$30 million pledged to support this community.
Duke and Duke-NUS forge new frontiers in climate health research with S$1million funding
The Dedicated Research Collaboration Pilot Project grant accelerates five promising areas of research collaboration, focusing on the effects of climate change on human health for the first time.
Singapore launches Mental Health Innovation Asia Hub at international symposium
The MHIN Asia Hub, launched in a collaboration between SingHealth Duke-NUS Global Health Institute and MHIN, aims to share innovative resources and ideas to promote mental health support across Asia.
Honouring excellence: Duke-NUS celebrates its Master Academic Clinicians
Ten clinician-leaders inducted into the Hall of Master Academic Clinicians for outstanding contributions to clinical care, research and mentorship in the SingHealth Duke-NUS Academic Medical Centre.
Hosted by Duke-NUS students, the 2025 Paediatric Brain and Solid Tumour Awareness Day at Gardens by the Bay offered young cancer patients and families vital support and community.
Read More PBSTA 2025: Strengthening bonds and building joy for young cancer patients
The inaugural forum discussed support strategies for clinician-scientists to achieve their aspirations in their dual roles, and saw over S$30 million pledged to support this community.
Read More Empowering Duke-NUS’ “Clinician Plus” at inaugural community forum
The Dedicated Research Collaboration Pilot Project grant accelerates five promising areas of research collaboration, focusing on the effects of climate change on human health for the first time.
Read More Duke and Duke-NUS forge new frontiers in climate health research with S$1million funding
The MHIN Asia Hub, launched in a collaboration between SingHealth Duke-NUS Global Health Institute and MHIN, aims to share innovative resources and ideas to promote mental health support across Asia.
Read More Singapore launches Mental Health Innovation Asia Hub at international symposium
Ten clinician-leaders inducted into the Hall of Master Academic Clinicians for outstanding contributions to clinical care, research and mentorship in the SingHealth Duke-NUS Academic Medical Centre.
Read More Honouring excellence: Duke-NUS celebrates its Master Academic Clinicians

Cosmopolitan
Duke-NUS marks 20 years with transformative S$30m in philanthropic gifts and pledges to boost next-gen medical breakthroughs
A S$5.5-million gift towards research from the Estate of Khoo Teck Puat and a S$200,000 scholarship from the HEAD Foundation, underpin Duke-NUS’ commitment to developing medical expertise.
Duke-NUS marks 20 years with transformative S$30m in philanthropic gifts and pledges to boost next-gen medical breakthroughs
A S$5.5-million gift towards research from the Estate of Khoo Teck Puat and a S$200,000 scholarship from the HEAD Foundation, underpin Duke-NUS’ commitment to developing medical expertise.
From parity to progress: Women in STEMM call for equity, mentorship and inclusive leadership at 2025 symposium
With over 350 attendees from the healthcare, academia and public sectors, symposium sparks cross-sector dialogue in leadership, mentorship and shaping a more equitable STEMM ecosystem in Singapore.
Golden vision: Game-changing myopia innovation EyeWonder™ wins $50,000 innovation award
The Duke-NUS Health Innovator Programme (D-HIP) 2025 concluded with Team ReVision winning the $50,000 top prize for an innovative device simplifying contact lens use for children to manage myopia.
PhDs, pivots and possibilities: rethinking career paths at the 17th DUNES Symposium
The symposium saw Dr Clement Yau and Dr Chua Li Min speak about making career pivots, while keynote speaker Professor Çagla Eroğlu discussed her shift from engineering to neurobiology.


Duke-NUS steps to new heights for fundraising: 15,000 floors to climb, countless lives to uplift
Project DOVE’s month-long “Climb-and-Walkathon” raised funds for medical missions to Nepal and Sri Lanka as participants aimed to climb 15,000 floors in support of underserved communities.
Hot to go: Deans’ Pancake Breakfast shows a batter way to serve
Leadership from Duke-NUS and SingHealth flipping pancakes to raise funds for student-led community projects Camp SIMBA and Project DOVE, fostering school spirit and camaraderie.
A homecoming of spirit: Alumni’s ambition and innovation celebrated at inaugural Duke-NUS Alumni Appreciation Dinner
Celebrating the School's growing alumni community, the dinner also highlighted the achievements of former students and their continued impact on healthcare and research.
Duke-NUS’ Professor Wong Tien Yin elected to the prestigious UK scientific academy, Royal Society
For his pioneering work on retinal imaging and using AI to detect eye diseases, Professor Wong Tien Yin has been elected a Fellow of the Royal Society, a first for a Singaporean doctor.
Duke-NUS celebrates 20 years of medical innovation with largest ever graduating class
The Class of 2025 includes 121 medical and doctoral students, including the landmark first batch of Masters in Patient Safety and Healthcare Quality graduates, unique to Southeast Asia.
Project DOVE’s month-long “Climb-and-Walkathon” raised funds for medical missions to Nepal and Sri Lanka as participants aimed to climb 15,000 floors in support of underserved communities.
Read More Duke-NUS steps to new heights for fundraising: 15,000 floors to climb, countless lives to uplift
Leadership from Duke-NUS and SingHealth flipping pancakes to raise funds for student-led community projects Camp SIMBA and Project DOVE, fostering school spirit and camaraderie.
Read More Hot to go: Deans’ Pancake Breakfast shows a batter way to serve
Celebrating the School's growing alumni community, the dinner also highlighted the achievements of former students and their continued impact on healthcare and research.
Read More A homecoming of spirit: Alumni’s ambition and innovation celebrated at inaugural Duke-NUS Alumni Appreciation Dinner
For his pioneering work on retinal imaging and using AI to detect eye diseases, Professor Wong Tien Yin has been elected a Fellow of the Royal Society, a first for a Singaporean doctor.
Read More Duke-NUS’ Professor Wong Tien Yin elected to the prestigious UK scientific academy, Royal Society
The Class of 2025 includes 121 medical and doctoral students, including the landmark first batch of Masters in Patient Safety and Healthcare Quality graduates, unique to Southeast Asia.
Read More Duke-NUS celebrates 20 years of medical innovation with largest ever graduating class









Infographics
All information accurate as of 31 March 2026 unless stated otherwise.
Publications & academic background presentations
01/08Publications & presentations
2011 – 2029 · All information accurate as of 31 Mar 2026